12:00 AM
 | 
Dec 22, 2008
 |  BC Week In Review  |  Company News  |  Deals

Generex, Pevion Biotech deal

The partners will use Pevion's virosome technology and Generex's Antigen Express Inc. subsidiary's immunotherapeutic peptides to develop vaccines and immunotherapeutics to treat cancer. Pevion's technology enhances...

Read the full 107 word article

User Sign in

Trial Subscription

Get a 4-week free trial subscription to BioCentury Week In Review

Article Purchase

$35 USD
More Info >